ATE319471T1 - Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit - Google Patents

Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit

Info

Publication number: ATE319471T1
Authority: AT; Austria
Prior art keywords: mantants; chemokine; oral bioavailability; improved oral; improved
Prior art date: 2002-04-04

Application number

AT03730169T

Other languages

English (en)

Inventor

Amanda Proudfoot

Marie Kosco-Vilbois

Timothy Wells

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-04

Filing date

2003-03-31

Publication date

2006-03-15

2003-03-31 Application filed by Applied Research Systems filed Critical Applied Research Systems

2006-03-15 Application granted granted Critical

2006-03-15 Publication of ATE319471T1 publication Critical patent/ATE319471T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03730169T 2002-04-04 2003-03-31 Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit ATE319471T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02100339		2002-04-04

Publications (1)

Publication Number	Publication Date
ATE319471T1 true ATE319471T1 (de)	2006-03-15

Family

ID=28685984

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03730169T ATE319471T1 (de)	2002-04-04	2003-03-31	Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit

Country Status (13)

Country	Link
US (1)	US7335350B2 (de)
EP (1)	EP1494703B1 (de)
JP (1)	JP2005529099A (de)
AT (1)	ATE319471T1 (de)
AU (1)	AU2003240758B2 (de)
CA (1)	CA2480692A1 (de)
DE (1)	DE60303929T2 (de)
DK (1)	DK1494703T3 (de)
ES (1)	ES2254938T3 (de)
IL (1)	IL164375A0 (de)
PT (1)	PT1494703E (de)
SI (1)	SI1494703T1 (de)
WO (1)	WO2003084562A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007113285A2 (en) *	2006-03-31	2007-10-11	Biotherapix Molecular Medicines S.L.U.	Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors
US8012474B2 (en)	2007-08-02	2011-09-06	Nov Immune S.A.	Anti-RANTES antibodies
WO2011031757A1 (en) *	2009-09-11	2011-03-17	Centocor Ortho Biotech Inc.	Serum markers for identification of cutaneous systemic sclerosis subjects
CA3101052A1 (en)	2018-05-28	2019-12-05	ORION Biotechnology Switzerland Sarl	Methods of inhibiting cerebral inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5739103A (en) *	1993-11-12	1998-04-14	Dana-Farber Cancer Institute	Chemokine N-terminal deletion mutations
US5871723A (en) *	1995-06-06	1999-02-16	The Regent Of The University Of Michigan	CXC chemokines as regulators of angiogenesis
WO1998006751A1 (en)	1996-08-16	1998-02-19	Research Corporation Technologies, Inc.	Mcp-3, rantes and mip-1alpha receptor antagonists
AU4561497A (en) *	1996-09-25	1998-04-17	British Biotech Pharmaceuticals Limited	Human rantes mutants incapable of aggregate formation
US6214540B1 (en) *	1997-03-26	2001-04-10	University Of Maryland Biotechnology Institute	Chemokines that inhibit immunodeficiency virus infection and methods based thereon
AU2415599A (en) *	1997-12-23	1999-07-19	Fondazione Centro San Raffaele Del Monte Tabor	Rantes mutants and therapeutic applications thereof
JP3349439B2 (ja)	1998-07-08	2002-11-25	日清紡績株式会社	ポリアセタール樹脂組成物
US6316420B1 (en) *	1998-07-28	2001-11-13	Technion Research And Development Foundation Ltd.	DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis
AU2740900A (en)	1999-01-29	2000-08-18	Millennium Pharmaceuticals, Inc.	Method of treating demyelinating inflammatory disease using ccr1 antagonists
UA77950C2 (en)	2000-10-04	2007-02-15	Applied Research Systems	Use of mutants of cc chemokines for treatment of multiple sclerosis

2003
- 2003-03-31 DE DE60303929T patent/DE60303929T2/de not_active Expired - Lifetime
- 2003-03-31 US US10/510,014 patent/US7335350B2/en not_active Expired - Fee Related
- 2003-03-31 SI SI200330205T patent/SI1494703T1/sl unknown
- 2003-03-31 CA CA002480692A patent/CA2480692A1/en not_active Abandoned
- 2003-03-31 WO PCT/EP2003/050084 patent/WO2003084562A1/en active IP Right Grant
- 2003-03-31 EP EP03730169A patent/EP1494703B1/de not_active Expired - Lifetime
- 2003-03-31 DK DK03730169T patent/DK1494703T3/da active
- 2003-03-31 AU AU2003240758A patent/AU2003240758B2/en not_active Ceased
- 2003-03-31 ES ES03730169T patent/ES2254938T3/es not_active Expired - Lifetime
- 2003-03-31 AT AT03730169T patent/ATE319471T1/de active
- 2003-03-31 JP JP2003581802A patent/JP2005529099A/ja active Pending
- 2003-03-31 PT PT03730169T patent/PT1494703E/pt unknown
2004
- 2004-10-03 IL IL16437504A patent/IL164375A0/xx unknown

Also Published As

Publication number	Publication date
DE60303929T2 (de)	2006-08-10
CA2480692A1 (en)	2003-10-16
EP1494703B1 (de)	2006-03-08
IL164375A0 (en)	2005-12-18
AU2003240758A1 (en)	2003-10-20
WO2003084562A1 (en)	2003-10-16
ES2254938T3 (es)	2006-06-16
EP1494703A1 (de)	2005-01-12
PT1494703E (pt)	2006-05-31
US20050220759A1 (en)	2005-10-06
DK1494703T3 (da)	2006-06-26
SI1494703T1 (sl)	2006-06-30
AU2003240758B2 (en)	2008-03-13
DE60303929D1 (de)	2006-05-04
JP2005529099A (ja)	2005-09-29
US7335350B2 (en)	2008-02-26

Similar Documents

Publication	Publication Date	Title
ATE416771T1 (de)	2008-12-15	N-ä4-(4-amino-2-ethyl-1h-imidazoä4,5-cüchinolin 1-yl)butylümethanesulfonamide, diese enthaltende pharmazeutische zusammensetzung und deren verwendung
DE60209785D1 (de)	2006-05-04	Gipszusammensetzung mit verbesserter deformationsstabilität
EA200300717A1 (ru)	2003-12-25	Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
RS50814B (sr)	2010-08-31	Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
EA200401345A1 (ru)	2005-08-25	Лечение гастропареза
SV1999000048A (es)	2000-07-04	Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
NO20012194L (no)	2001-05-03	CRF-reseptorantagonister og tilhörende fremgangsmåter
IT1318319B1 (it)	2003-08-25	Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
NO20015367D0 (no)	2001-11-02	Pegylert interferon <alfa>-CCR5-antagonist-kombinasjons HIV- terapi
CL2003001415A1 (es)	2005-01-07	Compuestos d derivados de naftil, quinolinil e isoquinolinil urea; composicion farmaceutica; y uso en el tratamiento y prevencion de condiciones de dolor y en el sibndrome del colon irritable y condiciones asociadas.
NO20012228L (no)	2001-05-04	CRF-reseptorantagonister og tilhörende fremgangsmåter
ATE319471T1 (de)	2006-03-15	Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit
AU2002332488A8 (en)	2004-02-25	R-bambuterol, its preparation and therapeutic uses
ATE339201T1 (de)	2006-10-15	Lasofoxifen enthaltende zusammensetzungen
DE60231057D1 (de)	2009-03-19	Chemokine mutanten, die als chemokine antagonisten wirken
ES2175356T3 (es)	2002-11-16	Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
DE60002984D1 (de)	2003-07-03	Neue verwendung von orexinrezeptorantagonisten
DE60317710D1 (de)	2008-01-03	Minimierung des gehalts von flüchtigenorganischen schwefelnebenprodukten bei der dimethylsulfatquaterinisierung vonmit hypophosphoriger säure hergestellten aminen
GB9910714D0 (en)	1999-07-07	Bipolar electrolyser
EA200400764A1 (ru)	2004-12-30	1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение
ITTO20030078A1 (it)	2003-08-22	Composizioni in particolare per l'impiego con elastomeri.
DE69832743D1 (de)	2006-01-19	Zusammensetzungen mit Polypeptiden die Eutypin Reductase Aktivität haben sowie Nukleotid Sequenzen die die Resistenz gegen die Eutypiose fördern
ATE328581T1 (de)	2006-06-15	Perkutane absorptionsbeschleuniger für die elektroporation
FI905922A0 (fi)	1990-11-30	Antagonister foer a-adrenerga receptorer.
ITRM930022V0 (it)	1993-02-04	Personal lifting by dr. benatouil.

Legal Events

Date	Code	Title	Description
2006-11-15	UEP	Publication of translation of european patent specification	Ref document number: 1494703 Country of ref document: EP
2011-04-15	EEFA	Change of the company name

Date

Code

Title

Description

2006-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1494703

Country of ref document: EP

2011-04-15

EEFA

Change of the company name